Chlorhexidine

CHEMBL790 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
505.4 g/mol
LogP
0.1
Phase
4

A broad-spectrum antiseptic agent that disrupts microbial cell membranes, effective against bacteria, fungi, and some viruses, used extensively for skin and wound disinfection, hand sanitization, and oral hygiene. It binds to skin and mucous membranes for prolonged residual antimicrobial activity. It is a cornerstone of infection control protocols in healthcare settings.

น้ำหนักโมเลกุล

505.4000 g/mol

LogP

0.10

TPSA

178.00 Ų

Lipinski RO5

ไม่ผ่าน

ด้านการรักษา

กลไกการออกฤทธิ์

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1

InChI

InChI=1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34)

Molecular Formula

C22H30Cl2N10

HBD / HBA

6 / 2

พันธะที่หมุนได้

13

อะตอมหนัก

34

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

A broad-spectrum antiseptic agent that disrupts microbial cell membranes, effective against bacteria, fungi, and some viruses, used extensively for skin and wound disinfection, hand sanitization, and oral hygiene. It binds to skin and mucous membranes for prolonged residual antimicrobial activity. It is a cornerstone of infection control protocols in healthcare settings.

Disrupts microbial cell membranes and denatures proteins on contact, producing rapid broad-spectrum antimicrobial activity on skin and wound surfaces.

Yes, Chlorhexidine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL790. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9552079. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.